Mirint, selected for the 2020 Startup Ontact Overseas Expansion, introduced wearable smart laser rhinitis treatment device KORHINA.
Mirint is a smart laser rhinitis treatment
device development company. The laser rhinitis treatment device KORHINA can be
controlled through the app as well as the device and provides the information
for prevention. Its technology is recognized at home and abroad. In November
2019, it received KGMP quality certification as a medical device from the MFDS,
and KFDA certification to certify its safety.
The company staff said, "We used
laser, so here are no side effects, and its small size makes it portable, with
the part that plugs into the nose and the body integrated so that patients can
use it easily. Anyone with allergic rhinitis can use it, and it is also
effective for anyone with rhinitis, whether it is chronic or acute, severe or
mild."
He then said, "Through this program, our
first goal is to receive good response from the investors in Europe, the US,
China, and abroad and actually get investment. We would also like to meet
partners related to investors and conduct sales cooperation" about the reason for
participating in this program.
2020 Startup Ontact Overseas Expansion
Project is a program designed to enable startups in the province that have
become stagnant due to COVID-19 to pioneer overseas markets by ontact, Active
support is being made through business cooperation between the Gyeonggi
Contents Agency Pangyo G-HUB specializing in supporting content startups and
KOTRA with its connection to overseas buyers, investors, and infrastructure.
RSS